TMO Leadership Update and 2026 Preview
The Translational Medicine Organization (TMO) at UCSF is pleased to announce an important leadership update as we close out the year and prepare for an exciting 2026.
Evan Marshman has been appointed as Acting Director of Administration, where he will oversee event logistics, internal coordination, and compliance operations. This transition reflects TMO’s continued commitment to strong leadership and operational consistency. Evan will be working closely with Executive Director Kim Madlangbayan and Director of Operations Makayla Nguyen to ensure smooth workflow integration and effective board collaboration.
“This role gives Evan the flexibility to shape administrative systems while supporting upcoming initiatives,” said Executive Director Kim Madlangbayan. “We’re confident in his ability to strengthen our organizational framework as TMO continues to grow.”
TMO is also proud to welcome Graduate Chair Representative, Himani Gupta, who will serve as a liaison for UCSF’s Graduate Division. Himani brings a wealth of academic insight and a strong commitment to interprofessional collaboration. Her involvement will help further TMO’s mission of bridging innovation across UCSF’s professional and graduate programs.
The board also announced that recruitment for new Graduate Division and Professional Chair positions will reopen in early 2026 to expand interdisciplinary representation. Interested students across UCSF’s schools and divisions are encouraged to apply when the call for applications goes live on CampusGroups and social media.
As the team looks ahead, TMO is already preparing for its first major event of 2026, continuing its mission to connect clinical care, research, and innovation across UCSF. More details will be shared early next quarter.
TMO remains grateful for the dedication of its members and the ongoing guidance of Faculty Advisor Dr. Joanne Chun.
Stay connected with us for upcoming announcements and event updates via
📘 UCSF CampusGroups
📸 Instagram @tmoatucsf